AHAS inhibitor - Names and Identifiers
AHAS inhibitor - Physico-chemical Properties
Molecular Formula | C19H12ClNO6S
|
Molar Mass | 417.82 |
Density | 1.466±0.06 g/cm3(Predicted) |
Boling Point | 664.8±55.0 °C(Predicted) |
Solubility | DMSO: ≥ 47 mg/mL |
Storage Condition | -20℃ |
In vitro study | BTB06584 inhibits F1 Fo-ATPase activity in an if1-dependent manner, has no effect on ATP synthesis, and limits the ischemia-induced damage caused by mitochondrial F1 Fo-ATP synthase inversion. |
In vivo study | BTB06584 restores defective hemoglobin synthesis in zebrafish pintage (pnt) mutants without causing significant toxicity. |
AHAS inhibitor - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 2.393 ml | 11.967 ml | 23.934 ml |
5 mM | 0.479 ml | 2.393 ml | 4.787 ml |
10 mM | 0.239 ml | 1.197 ml | 2.393 ml |
5 mM | 0.048 ml | 0.239 ml | 0.479 ml |
Last Update:2024-01-02 23:10:35
AHAS inhibitor - Introduction
BTB06584 is an organic compound with the chemical name 4,4 '-bis (phenylmethyl) diphenylbis (deoxycholic acid).
Nature:
-Appearance: Colorless crystalline solid
-Solubility: Soluble in organic solvents, insoluble in water
-Melting point: About 180-182 degrees Celsius
Use:
BTB06584 can be used to study the biological activity of cholesterol and cholic acid analogs. It is widely used in drug development and biochemical laboratories to study cholesterol metabolism, hormone regulation and intestinal absorption.
Preparation Method:
The preparation of BTB06584 is generally carried out by synthetic chemical methods. The specific preparation method may vary due to the research purpose, experimental conditions and other factors.
Safety Information:
- BTB06584 is a chemical and should be used in accordance with relevant safety guidelines and laboratory practices.
-Avoid skin and eye contact when touching, and maintain good ventilation conditions.
-in the operation and storage should avoid contact with oxidants, strong acid or alkali and other substances, so as to avoid dangerous reaction.
-If inhaled or ingested, seek medical advice immediately and show detailed information on the compound.
Last Update:2024-04-09 19:05:02